US2023018246A1PendingUtilityA1
Pyrrolidine carboxamido derivatives and methods for preparing and using the same
Assignee: RESEARCH & BUSINESS FOUND SUNGKYUNKWAN UNIVPriority: Jul 8, 2015Filed: Aug 3, 2022Published: Jan 19, 2023
Est. expiryJul 8, 2035(~9 yrs left)· nominal 20-yr term from priority
Inventors:Kwangho LeeSang Dal RheeGildon ChoiImran AliChong Hak ChaeMoon-Kook JeonSeok-Hee ParkYoun Sook Lee
A61K 31/4025C07K 5/1016C07K 5/1024A61P 1/00C07D 403/06C07K 5/0823C07K 5/1008A61K 38/00C07D 207/04C07D 207/10A61K 47/542A23V 2200/30A61K 31/40A23L 33/10C07K 5/0821
73
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Pyrrolidine carboxamido derivatives, optical isomers thereof, and salts thereof that are able to prevent, improve, and/or treat inflammatory conditions, including inflammatory bowel disease, and methods for preparing and using the same are provided.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . A compound of the following Formula:
an optical isomer thereof, or a pharmaceutically acceptable salt thereof.
28 . A pharmaceutical composition comprising the compound, the optical isomer, or the salt of claim 1 , and a pharmaceutically acceptable carrier.
29 . The pharmaceutical composition of claim 28 , which is a formulation for oral administration.
30 . A method for preparing a compound of Formula 1, an optical isomer thereof, or a pharmaceutically acceptable salt thereof, which comprises:
reacting a compound 2 with a compound 3 to prepare a compound 4; hydrolyzing the compound 4 in the presence of a base to prepare a compound 5; reacting the compound 5 with a compound 6 to prepare a compound 7; hydrolyzing the compound 7 in the presence of a base to prepare a compound 8; reacting the compound 8 with a compound 9 to prepare a compound 10; hydrolyzing the compound 10 in the presence of a base to prepare the compound of Formula 1:
wherein
n is 0, 1, or 2;
A is -a 1 -, which is an amino acid independently selected from the group consisting of alanine, (Ala, A), arginine (Arg, R), asparagine (Asn, N), aspartic acid (Asp, D), cysteine (Cys, C), glutamic acid (Glu, E), glutamine (Gln, Q), glycine (Gly, G), histidine (His, H), isoleucine (Ile, I), leucine (Leu, L), lysine (Lys, K), methionine (Met, M), phenylalanine (Phe, F), proline (Pro, P), serine (Ser, S), threonine (Thr, T), tryptophan (Trp, W), tyrosine (Tyr, Y), and valine (Val, V), both terminal ends of the amino acid being coupled to a carbonyl group or an amine group by an amide bond; and
R 1 is a straight chain or branched chain C 1-36 alkyl, a straight chain or branched chain C 2-36 alkenyl including at least one double bond, or a straight chain or branched chain C 2-36 alkynyl including at least one triple bond.
31 . The method of claim 30 , wherein
n is 0, 1, or 2; a 1 is
both terminal ends of which is coupled to a carbonyl group or amide group thereof by an amide bond; and
R 1 is a straight chain or branched chain C 1-36 alkyl.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.